Drugs / Tomeka®
last change Dec 2022 re-read 3 minutes ago

Tomeka®

Other / unclassified

Developed for
COVID-19
Investigated by
Centre Médical de Kinshasa (CMK) · Guyguy K Tshima, MD

Trials 1

202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04537585 Nov 2020 → Nov 2022 COVID-19 Guyguy K Tshima, MD Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tomeka ClinicalTrials.gov intervention name — accepted as the source's own label NCT04537585 ↗
Modality Other / unclassified “The intervention is education that needs to be evaluated with the suggested Tomeka® foods (nutraceuticals).” NCT04537585 ↗